| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |